Combining deep mutational scanning and Next-Generation Protein Sequencing to harness dominant protein variants to develop DNA repair inhibitors
AACR 2026 Poster – The most clinically effective DNA repair enzyme inhibitors convert the protein target itself into a therapeutic agent. Topoisomerase poisons block the completion of the topoisomerase reaction resulting in a genotoxic DNA-protein adduct. Similar mechanisms underlie clinically relevant PARP inhibitors and other emerging therapeutics targeting DNA Damage Response proteins. Which repair proteins […]